Adi Zoref‐Lorenz

Cincinnati Children's Hospital Medical Center

Also affiliated with Tel Aviv University, Tel Aviv Sourasky Medical Center, Meir Medical Center

MedicineImmunology and MicrobiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT”.

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT

Blood Advances(2023)10.1182/bloodadvances.2022009478

N/A

0.343DataRank · unranked

5 citations

Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen +22 more

A Case of Chronic Lymphocytic Leukemia Complicated by Hemophagocytic Lymphohistiocytosis: Identifying the Aberrant Immune Response

Journal of General Internal Medicine(2022)10.1007/s11606-022-07395-7

N/A

0DataRank · unranked

5 citations

Mona Yuklea, Guy Topaz, Michael B. Jordan, Martin Ellis, Adi Zoref‐Lorenz

The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in patients with lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024014005

N/A

0DataRank · unranked

8 citations

Jun Murakami, Ronit Gurion, Swaminathan P. Iyer, Uri Abadi, Inbar Cohen +16 more